Samaritan Pharma: Early Stage Alzheimer's Disease Diagnostic Patent Issued in Australia
May 29, 2007 11:07 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, May 29, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has received a notice that the Australian patent application...
Shire Human Genetic Therapies AB Signs Exclusive Marketing and Distribution Deal With Samaritan to Launch REPLAGAL for Fabry Disease in Greece and Cyprus
May 22, 2007 09:37 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, May 22, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it has signed a second exclusive marketing and...
Samaritan Breast Cancer Diagnostic Issued U.S. Patent
May 15, 2007 09:51 ET
|
Samaritan Pharmaceuticals, Inc.
Unique Advantages:
Faster Prognosis With Breast Cancer Diagnosis Taking 1-7 Days Compared
to the Traditional 3-Weeks
Determines Breast Cancer Tumor Aggressiveness and Likelihood of Cancer
...
Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimer's Drug
May 03, 2007 09:53 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, May 3, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce positive results were attained with its late-stage...
Samaritan to Highlight Its Novel Alzheimer's Drug Caprospinol (SP-233) At BIO International Convention 2007
May 01, 2007 09:35 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, May 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today, it will present its late-stage preclinical drug candidates at...
Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000
April 10, 2007 09:28 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, April 10, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has received a notice that a European Patent has been...
AMEX Panel Grants Samaritan Continued AMEX Listing Pursuant to May 31st Extension to Allow for 10Q Filing Demonstrating It Has Regained Compliance
April 05, 2007 06:41 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, April 5, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) announced today that on April 3, 2007, the American Stock Exchange ("AMEX") notified Samaritan Pharmaceuticals,...
Samaritan Pharma Partners PII HIV Drug to Pharmaplaz; Upfront Payment $10 Million
March 28, 2007 11:53 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, March 28, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, and Pharmaplaz, Ltd., a private Irish healthcare company, announced today...
Samaritan Pharma's SP-233 Featured in Zillion Business Review Article
March 26, 2007 09:55 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, March 26, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today it was featured in the eighteenth edition 2007 of Zillion...
Samaritan's In-Licensed AMPHOCIL Awarded 94 Percent Price Increase With Pricing Approval in Greece
March 08, 2007 09:46 ET
|
Samaritan Pharmaceuticals, Inc.
Sales Launch in Greece Expected Next Month
AMPHOCIL is the First of Nine Revenue Producing Products In-Licensed
to Samaritan
LAS VEGAS, March 8, 2007 (PRIME NEWSWIRE) -- Samaritan...